| Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis AD Henderson, BFC Butler-Cole, J Tazare, LA Tomlinson, M Marks, M Jit, ... eClinicalMedicine 72, 2024 | 1 | 2024 |
| Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT) O Carlile, A Briggs, AD Henderson, BFC Butler-Cole, J Tazare, ... The Lancet Regional Health–Europe 40, 2024 | | 2024 |
| Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study GI Cezard, RE Denholm, R Knight, Y Wei, L Teece, R Toms, HJ Forbes, ... Nature Communications 15 (1), 2173, 2024 | | 2024 |
| During the COVID‐19 pandemic 20 000 prostate cancer diagnoses were missed in England A Lemanska, C Andrews, L Fisher, S Bacon, A Mehrkar, P Inglesby, ... BJU international, 2024 | | 2024 |
| OpenSAFELY: Measuring BMI in 22 million patients in England R Park, C Andrews, HJ Curtis, J Massey, WJ Hulme, A Mehrkar, S Bacon, ... Wellcome Open Research 9 (26), 26, 2024 | | 2024 |
| Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPP (preprint) AL Schaffer, CD Andrews, AD Brown, R Croker, WJ Hulme, L Nab, ... | | 2024 |
| The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England … C Cunningham, O Macdonald, AL Schaffer, AD Brown, M Wiedemann, ... medRxiv, 2024.05. 08.24306990, 2024 | | 2024 |
| Comparative safety and effectiveness of Pfizer BA. 4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in … OpenSAFELY Collaborative, CD Andrews, E Prestige, EPK Parker, ... medRxiv, 2024.03. 15.24304277, 2024 | | 2024 |
| Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPP AL Schaffer, CD Andrews, AD Brown, R Croker, WJ Hulme, L Nab, ... medRxiv, 2024.02. 23.24303238, 2024 | | 2024 |
| Educational interventions delivered to prescribing advisers to influence primary care prescribing: a very low-cost pragmatic randomised trial using routine data from … HJ Curtis, B MacKenna, B Reddy, AJ Walker, S Bacon, R Perera, ... medRxiv, 2024.01. 05.24300907, 2024 | | 2024 |
| Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study X Zhong, D Ashiru-Oredope, A Pate, GP Martin, A Sharma, P Dark, ... EClinicalMedicine 66, 2023 | 3 | 2023 |
| Healthcare use attributable to COVID-19: a propensity-matched national electronic health records cohort study of 249,390 people in Wales, UK J Kennedy, M Parker, M Seaborne, M Mhereeg, A Walker, V Walker, ... BMC medicine 21 (1), 1-16, 2023 | 1 | 2023 |
| Fit notes associated with COVID-19 in 24 million patients’ primary care records: A cohort study in OpenSAFELY-TPP AL Schaffer, RY Park, J Tazare, K Bhaskaran, B MacKenna, S Denaxas, ... medRxiv, 2023.07. 28.23293269, 2023 | | 2023 |
| Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults’ primary care records in England … L Fisher, HJ Curtis, R Croker, M Wiedemann, V Speed, C Wood, A Brown, ... eLife 12, e84673, 2023 | | 2023 |
| Impact of vaccination on the association of COVID-19 with arterial and venous thrombotic diseases: an OpenSAFELY cohort study using linked electronic health records G Cezard, R Denholm, R Knight, Y Wei, L Teece, R Toms, H Forbes, ... | | 2023 |
| Association between living with children, vaccination, and outcomes from COVID-19: an OpenSAFELY cohort study of 12 million adults in England during 2021–22 TE Cowling, H Forbes, K Wing, J Tazare, A Schultze, CE Morton, S Bacon, ... Wellcome Open Research 8 (293), 293, 2023 | | 2023 |
| Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based … RE Costello, J Tazare, D Piehlmaier, E Herrett, EPK Parker, B Zheng, ... EClinicalMedicine 61, 2023 | 1 | 2023 |
| OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate AD Brown, L Fisher, HJ Curtis, M Wiedemann, WJ Hulme, V Speed, ... British Journal of Clinical Pharmacology, 2023 | 1 | 2023 |
| Primary Care Post-COVID syndrome Diagnosis and Referral Coding R Willans, G Allsopp, P Jonsson, F Glen, J Macleod, Y Wei, F Greaves, ... medRxiv, 2023.05. 23.23289798, 2023 | | 2023 |
| A National Audit of Pancreatic Enzyme Prescribing in Pancreatic Cancer from 2015 to 2023 in England Using OpenSAFELY-TPP A Lemanska, C Andrews, L Fisher, B Butler-Cole, A Mehrkar, KJ Roberts, ... Seminars in Oncology Nursing, 151439, 2023 | 6* | 2023 |
Ben GoldacreUniversity of Oxford在 phc.ox.ac.uk 的电子邮件经过验证
